/
/
/

Haleos Labs Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-5%2%-3%
-5%15%-5%
-14%44%37%
11%9%7%9%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
LAURUSLABS
CIPLA
DRREDDY
MANKIND
AUROPHARMA
LUPIN
HALEOSLABS
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,731.5₹424466 Cr35.0912.0762.82₹11479 Cr
8,992₹246222 Cr84.1834.04128.41₹2568 Cr
4,575.7₹176301 Cr80.8316.7297.06₹2163 Cr
1,136.2₹112818 Cr259.4262.53₹5040 Cr
2,030.1₹110823 Cr101.366.829.25₹889 Cr
1,306.5₹107447 Cr31.889.7757.87₹3879 Cr
1,213.3₹103471 Cr32.115.3263.99₹4196 Cr
2,335₹97850 Cr47.913.7571.08₹1913 Cr
1,662.8₹96836 Cr26.0817.9596.84₹3505 Cr
1,949.5₹89629 Cr16.2130.95154.35₹5333 Cr
1,560₹467 Cr29.588.76104.83₹17 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018
₹73 Cr₹75 Cr₹95 Cr₹81 Cr₹83 Cr₹89 Cr₹85 Cr₹78 Cr₹93 Cr₹90 Cr₹72 Cr₹69 Cr₹75 Cr₹64 Cr₹88 Cr₹81 Cr₹82 Cr₹96 Cr₹91 Cr₹87 Cr₹76 Cr₹83 Cr₹67 Cr₹62 Cr₹55 Cr₹46 Cr₹47 Cr₹76 Cr₹92 Cr₹107 Cr₹103 Cr
₹46 L₹2 Cr₹18 L₹42 L₹100 L₹2 Cr₹6 L₹2 Cr₹44 L₹2 Cr₹58 L₹34 L₹61 L₹2 Cr₹49 L₹15 L₹31 L₹2 Cr₹4 L₹67 L₹7 L₹1 Cr₹61 L₹28 L₹30 L₹87 L₹33 L₹82 L₹27 L₹2 Cr₹13 L
₹73 Cr₹77 Cr₹95 Cr₹82 Cr₹84 Cr₹91 Cr₹85 Cr₹81 Cr₹93 Cr₹92 Cr₹73 Cr₹70 Cr₹75 Cr₹66 Cr₹89 Cr₹81 Cr₹83 Cr₹97 Cr₹91 Cr₹87 Cr₹76 Cr₹84 Cr₹67 Cr₹62 Cr₹55 Cr₹47 Cr₹47 Cr₹77 Cr₹92 Cr₹109 Cr₹103 Cr
₹68 Cr₹75 Cr₹85 Cr₹72 Cr₹75 Cr₹85 Cr₹76 Cr₹74 Cr₹80 Cr₹82 Cr₹66 Cr₹65 Cr₹76 Cr₹64 Cr₹82 Cr₹76 Cr₹76 Cr₹92 Cr₹85 Cr₹80 Cr₹70 Cr₹76 Cr₹62 Cr₹56 Cr₹50 Cr₹44 Cr₹46 Cr₹70 Cr₹84 Cr₹101 Cr₹92 Cr
₹10 Cr₹6 Cr₹14 Cr₹14 Cr₹13 Cr₹10 Cr₹13 Cr₹11 Cr₹17 Cr₹14 Cr₹10 Cr₹8 Cr₹3 Cr₹5 Cr₹10 Cr₹8 Cr₹9 Cr₹8 Cr₹8 Cr₹10 Cr₹8 Cr₹10 Cr₹7 Cr₹8 Cr₹7 Cr₹4 Cr₹3 Cr₹9 Cr₹10 Cr₹9 Cr₹12 Cr
₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹99 L₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr
₹3 Cr₹91 L₹9 Cr₹8 Cr₹7 Cr₹4 Cr₹7 Cr₹5 Cr₹11 Cr₹7 Cr₹4 Cr₹2 Cr-₹3 Cr₹2 Cr₹6 Cr₹4 Cr₹5 Cr₹9 Cr₹4 Cr₹14 Cr₹5 Cr₹7 Cr₹4 Cr₹5 Cr₹4 Cr₹1 Cr-₹13 L₹6 Cr₹7 Cr₹6 Cr₹9 Cr
₹2 Cr₹34 L₹7 Cr₹6 Cr₹4 Cr₹3 Cr₹5 Cr₹3 Cr₹7 Cr₹6 Cr₹4 Cr-₹44 L-₹4 Cr₹2 Cr₹4 Cr₹3 Cr₹2 Cr₹8 Cr₹2 Cr₹10 Cr₹4 Cr₹5 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr-₹34 L₹4 Cr₹5 Cr₹5 Cr₹6 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
————————
₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr
₹211 Cr₹194 Cr₹174 Cr₹166 Cr₹149 Cr₹126 Cr₹113 Cr₹103 Cr
₹211 Cr₹194 Cr₹174 Cr₹166 Cr₹149 Cr₹126 Cr₹113 Cr₹103 Cr
₹214 Cr₹197 Cr₹177 Cr₹169 Cr₹152 Cr₹129 Cr₹116 Cr₹106 Cr
₹16 Cr₹15 Cr₹17 Cr₹20 Cr₹13 Cr₹0₹0₹0
₹50 Cr₹18 Cr₹33 Cr₹51 Cr₹35 Cr₹34 Cr₹32 Cr₹22 Cr
₹0₹0₹0₹4 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr
₹13 Cr₹11 Cr₹12 Cr₹13 Cr₹11 Cr₹11 Cr₹10 Cr₹9 Cr
₹81 L₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹6 Cr₹94 L₹0
₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr
₹69 Cr₹36 Cr₹52 Cr₹73 Cr₹56 Cr₹59 Cr₹50 Cr₹39 Cr
————————
₹61 Cr₹53 Cr₹59 Cr₹60 Cr₹78 Cr₹67 Cr₹49 Cr₹98 Cr
₹48 Cr₹37 Cr₹37 Cr₹42 Cr₹29 Cr₹25 Cr₹16 Cr₹14 Cr
₹45 Cr₹50 Cr₹47 Cr₹30 Cr₹27 Cr₹20 Cr₹21 Cr₹13 Cr
₹7 Cr₹11 Cr₹6 Cr₹5 Cr₹9 Cr₹6 Cr₹5 Cr₹7 Cr
₹162 Cr₹151 Cr₹149 Cr₹137 Cr₹143 Cr₹119 Cr₹90 Cr₹132 Cr
₹460 Cr₹399 Cr₹395 Cr₹398 Cr₹364 Cr₹307 Cr₹256 Cr₹276 Cr
₹14 Cr₹19 Cr₹18 Cr₹5 Cr₹5 Cr₹7 Cr₹5 Cr₹4 Cr
₹109 Cr₹84 Cr₹98 Cr₹99 Cr₹77 Cr₹64 Cr₹64 Cr₹47 Cr
————————
₹363 Cr₹312 Cr₹290 Cr₹281 Cr₹177 Cr₹164 Cr₹150 Cr₹136 Cr
₹95 Cr₹80 Cr₹66 Cr₹52 Cr₹35 Cr₹34 Cr₹25 Cr₹18 Cr
₹268 Cr₹232 Cr₹223 Cr₹228 Cr₹142 Cr₹130 Cr₹124 Cr₹117 Cr
₹10 Cr₹40 L₹6 Cr₹85 L₹51 Cr₹38 Cr₹16 Cr₹3 Cr
₹4 L₹4 L₹4 L₹4 L₹4 L₹4 L₹4 L₹4 L
₹4 L₹4 L₹4 L₹4 L₹4 L₹4 L₹4 L₹4 L
₹13 Cr₹7 Cr₹6 Cr₹7 Cr₹7 Cr₹8 Cr₹6 Cr₹5 Cr
₹0₹0₹0₹0₹0₹0₹0₹1 Cr
₹291 Cr₹239 Cr₹235 Cr₹236 Cr₹201 Cr₹176 Cr₹146 Cr₹128 Cr
————————
₹80 Cr₹67 Cr₹81 Cr₹86 Cr₹85 Cr₹62 Cr₹64 Cr₹81 Cr
₹61 Cr₹69 Cr₹51 Cr₹46 Cr₹34 Cr₹34 Cr₹22 Cr₹41 Cr
₹2 Cr₹2 Cr₹1 Cr₹4 Cr₹4 Cr₹11 Cr₹8 Cr₹3 Cr
₹67 L₹64 L₹2 Cr₹3 Cr₹3 Cr₹83 L₹6 Cr₹11 Cr
₹24 Cr₹21 Cr₹24 Cr₹23 Cr₹38 Cr₹23 Cr₹11 Cr₹13 Cr
₹169 Cr₹160 Cr₹160 Cr₹163 Cr₹164 Cr₹131 Cr₹110 Cr₹149 Cr
₹7 Cr₹9 Cr₹11 Cr₹26 Cr₹21 Cr₹12 Cr₹20 Cr₹17 Cr
₹460 Cr₹399 Cr₹395 Cr₹398 Cr₹364 Cr₹307 Cr₹256 Cr₹276 Cr
₹706₹650₹585₹558₹504₹427₹383₹352
₹706₹650₹585₹558₹504₹427₹383₹352

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
₹25 Cr₹26 Cr₹10 Cr₹14 Cr₹20 Cr₹20 Cr₹15 Cr₹25 Cr
₹18 Cr₹25 Cr₹21 Cr₹16 Cr₹14 Cr₹10 Cr₹11 Cr₹9 Cr
₹85 L-₹8 Cr-₹4 Cr-₹12 Cr-₹38 Cr₹10 Cr-₹8 Cr₹2 Cr
₹44 Cr₹43 Cr₹27 Cr₹18 Cr-₹4 Cr₹40 Cr₹18 Cr₹37 Cr
₹37 Cr₹34 Cr₹24 Cr₹15 Cr-₹11 Cr₹35 Cr₹15 Cr₹30 Cr
-₹58 Cr-₹15 Cr-₹18 Cr-₹31 Cr-₹7 Cr-₹26 Cr-₹27 Cr-₹44 Cr
₹21 Cr-₹19 Cr-₹7 Cr₹17 Cr₹11 Cr-₹3 Cr₹12 Cr₹15 Cr
₹71 L-₹7 L-₹71 L₹29 L-₹8 Cr₹6 Cr-₹3 L₹1 Cr
₹50 L₹57 L₹1 Cr₹99 L₹9 Cr₹2 Cr₹2 Cr₹82 L
₹1 Cr₹50 L₹57 L₹1 Cr₹99 L₹9 Cr₹2 Cr₹2 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)1,550.40
Volume (₹)938.00
High (₹)1,567.00
Upper Circuit1,855.30
Low (₹)1,536.70
Lower Circuit1,236.90
Prev Close1,546.10
52W High (₹)1,774.00
Price1,567.00
52W Low (₹)1,091.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)467.43 Cr
Div. Yield (%)0.10
PE Ratio29.58
Debt to Equity0.51
Price to Book1.70
Book Value706.34
EPS (TTM)52.27
Face Value10.00
ROE (%)8.68

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
HALEOSLABSNSE
LTP
1W Low
1W High
Market cap (₹)
1746.4-13.6 (-0.77%)
1725.50
1776.60
4,24,466Cr
9023-317 (-3.39%)
8937.50
9431.50
2,46,222Cr
4580-76.9 (-1.65%)
4551.80
4682
1,76,301Cr
1124.7+7.2 (0.64%)
1107.30
1150.90
1,12,818Cr
2036.9+0.3 (0.01%)
2007.80
2069.20
1,10,823Cr
1314.6+13.6 (1.05%)
1300.20
1333.30
1,07,447Cr
1216+19 (1.59%)
1196.90
1250.70
1,03,471Cr
2335-33.5 (-1.41%)
2317.50
2426.80
97,850Cr
1662.9-30.1 (-1.78%)
1654.10
1715
96,836Cr
1953.2-3.3 (-0.17%)
1925.70
1964.90
89,629Cr
1567+3.3 (0.21%)
1525.20
1586.20
467Cr

Haleos Labs Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹9.58Cr; with other income of ₹46.3Lakh, profit before interest and tax came to ₹5.34Cr. Interest expense was ₹1.9Cr; PBT before exceptional items stood at ₹3.44Cr. Cost mix (full year): raw materials ₹149.91Cr; employee cost ₹59.54Cr; depreciation ₹4.24Cr; other expenses ₹63.82Cr. Basis: consolidated annual results.

Haleos Labs Ltd Quaterly Results Key Takeaways

Haleos Labs Ltd reported ₹72.94Cr total income from operations in Jun 2026, softer than ₹75.14Cr in Mar 2026 but higher than ₹82.5Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹9.58Cr; with other income of ₹46.3Lakh, profit before interest and tax came to ₹5.34Cr. Interest expense was ₹1.9Cr, taking profit before tax to ₹3.44Cr. After tax of ₹1.6Cr, profit after tax stood at ₹1.84Cr (vs ₹34.4Lakh in Mar 2026 and ₹4.38Cr in Jun 2025).